2ϩ
in activation of myosin light chain phosphorylation. Sr 2ϩ cannot replace Ca 2ϩ in facilitation of agonist-activated Ca 2ϩ -dependent nonselective cation channels. It is not known whether Sr 2ϩ can replace Ca 2ϩ in small G protein-mediated sensitization of phosphorylation. To explore mechanisms involved in ␣-receptor-activated contractions in smooth muscle, effects of replacing Ca 2ϩ with Sr 2ϩ were examined in rat portal vein. Norepinephrine (NE) at Ͼ3.0 ϫ 10 Ϫ7 M in the presence of Ca 2ϩ resulted in a strong sustained contraction, whereas this sustained component was absent in the presence of Sr 2ϩ ; only the amplitude of phasic contractions increased. Pretreatment with low (ϳ0.05 mM) free Ca 2ϩ followed by 2.5 mM Sr 2ϩ resulted in a sustained component of the NE response. In ␤-escin-permeabilized preparations, phenylephrine in the presence of GTP or guanosine 5Ј-O-(3-thiotriphosphate) alone induced sensitization to Sr 2ϩ . In conclusion, a Ca 2ϩ -regulated membrane/channel process is required for the sustained component of NE responses in rat portal vein. Sensitization alone is not responsible for the sustained phase of the NE contraction. vascular smooth muscle; calcium sensitization AGONIST STIMULATION OF SMOOTH muscle initiates a complex series of events leading to activation of the contractile proteins. For most agonists, this involves both membrane depolarization, with an associated influx of Ca 2ϩ , and activation of membrane potential-independent processes [i.e., the electromechanical and pharmacomechanical coupling pathways (38) ]. The main cellular event in activation is a rise in free Ca 2ϩ concentration ([Ca 2ϩ ]), initiating myosin light chain phosphorylation (14) . However, agonist stimulation of smooth muscle also involves a sensitization of the contractile process to Ca 2ϩ (2) . The sensitization of the contractile proteins to Ca 2ϩ was originally described in experiments on intact smooth muscle (12, 23, 25, 34) , where force was correlated with measured levels of free Ca 2ϩ . The mechanisms of Ca 2ϩ sensitization have been further examined in skinned preparations, where the free [Ca 2ϩ ] can be controlled. Sensitization to Ca 2ϩ has substantial effects on force at low free [Ca 2ϩ ] (18) and has been suggested to strongly contribute to the tonic (or sustained) phase of agonist-induced contractions via small G protein-associated pathways (37) . Consistent with this view, inhibition of G protein (rhoA)-mediated Ca 2ϩ sensitization results in loss of sustained force development in the rabbit portal vein activated by norepinephrine (9) and in the guinea pig ileum activated by carbachol (23, 28) . Recently, a Ca 2ϩ -independent kinase, associated with myofilaments, was found and postulated to contribute to sensitization and Ca 2ϩ -independent contraction (41) . This raises the following question: Are mechanisms associated with sustained [Ca 2ϩ ] increase required, or is the sensitization alone sufficient for activation of the sustained contraction phase in the intact smooth muscle? Sr 2ϩ can replace Ca 2ϩ in many biological systems. In smooth muscle, Sr 2ϩ can activate myosin light chain phosphorylation and contraction of chemically skinned muscle fibers (11, 13, 35, 36) , although the concentration-force relationship is shifted toward higher concentrations in the presence of Sr 2ϩ than in the presence of Ca 2ϩ . In intact muscle, Sr 2ϩ can support spontaneous contractile activity and contractions induced by membrane depolarization (1, 11, 40 . The aim of this study was to determine whether sensitization of the phosphorylation process is the only mechanism of physiological importance in control of the sustained phase of the agonist-induced contraction in intact tissue. We used the rat portal vein and examined norepinephrine-induced contractions in intact tissue in the presence of Sr 2ϩ and Ca 2ϩ . To study the sensitization, we determined responses to guanosine 5Ј-O-(3-thiotriphosphate) (GTP␥S) and norepinephrine/GTP in permeabilized preparations at fixed concentrations of Ca 2ϩ and Sr 2ϩ .
METHODS
Muscle fiber preparations. Female Sprague-Dawley rats (150-200 g) were obtained from Möllegaard (M & B, Ry, Denmark). The animals were killed by cervical dislocation, and the portal veins were removed and dissected free of connective tissue.
Experiments on intact preparations. The portal vein was opened longitudinally and used whole or split longitudinally into two equal parts. The strips, 7-9 mm long, were mounted in open organ baths at 37°C, using thin silk thread, between a stainless steel pin on an adjustable stand and a transducer (model FT03, Grass Instrument, Freeport, IL) for recording of isometric force. The preparations were equilibrated in physiological saline solution (PSS; see composition below) with 2.5 mM Ca 2ϩ for 1 h at a passive tension corresponding to optimal length for active force (24) . In each muscle preparation, a reference contraction was recorded after addition of 80 mM KCl from a 3 M stock solution to the PSS with 2.5 mM CaCl 2. This activation method, which depolarizes in a nonisotonic solution, enables a fast change in KCl concentration without solution exchange and gives reproducible contractions. These contractions were stronger than those obtained using isosmolar substitution of Na ϩ for K ϩ , probably due to cell swelling shown to occur after Na ϩ /K ϩ isosmotic replacement (17) . We used the plateau force of the 80 mM KCl in 2.5 mM CaCl2 contractions as a reference for normalization of all later force responses.
We performed Sr 2ϩ and Ca 2ϩ experiments in varying order on the same fiber. Previous reports have shown that the sarcoplasmic reticulum is depleted after 5-6 min in Ca 2ϩ -free solution at 20°C (6) . To ensure that all intracellular stores were emptied, preparations were kept in Ca 2ϩ /Sr 2ϩ -free PSS for 10 min, and thereafter the muscle was challenged three times with 10 Ϫ5 M norepinephrine in this solution. The contractile responses were completely absent, showing that intracellular stores are emptied under these conditions.
The Norepinephrine concentration-force relationships were examined in Ca 2ϩ and Sr 2ϩ solutions. The muscle preparations were held in PSS with 2.5 mM CaCl 2 or SrCl2 and activated with different concentrations of norepinephrine. Force was recorded for 5-10 min, and the muscles were relaxed for 5 min in PSS between contractions. Peak and sustained force were measured and expressed relative to reference force.
The Ca 2ϩ dependence of the sustained phase after norepinephrine-induced activation was examined using the following protocol. The preparations were equilibrated in Ca 2ϩ / Sr 2ϩ -free PSS with 1 mM EGTA for 10 min. Then EGTA concentration was decreased to 0.1 mM, and 10 Ϫ5 M norepinephrine was added. After 30 s, 2.5 mM SrCl 2 was added. One set of experiments was performed at a low free [Ca 2ϩ ] (0.15 mM CaCl2 added to the 0.1 mM EGTA solution) and one set at zero free [Ca 2ϩ ] (no CaCl2 added). The free [Ca 2ϩ ] at 0.15 CaCl2 and 0.1 EGTA is estimated to be 50 M. This would change to a maximum of 55 M when 2.5 mM SrCl2 was added, since the binding constant for Sr 2ϩ to EGTA is low (11) . As a control experiment to determine the force responses at maximal [Ca 2ϩ ], the procedure described above was performed with 2.5 mM CaCl2, instead of 2.5 mM SrCl2.
Experiments on ␤-escin-permeabilized preparations. The portal vein was prepared as described above, and then four to six 5-to 7-mm-long longitudinal strips were cut from each vein. The strips were mounted horizontally on small metal clips between the extended arm of a force transducer (Scientific Instruments, Heidelberg, Germany) and a steel pin, enabling length adjustment. The experiments were carried out at ambient temperature (ϳ23°C) in 1-ml cups. The strips were equilibrated for ϳ45 min in HEPES-buffered PSS (see below) before a norepinephrine (10 Ϫ5 M) test contraction was made. The preparations were chemically permeabilized using ␤-escin essentially as described previously (19, 28) . The strips were thoroughly relaxed in Ca 2ϩ -free HEPES-buffered PSS for 10 min. After the preparations were transferred to relaxing solution for 5 min, they were treated with relaxing solution plus 50 M ␤-escin for 35 min. Finally, the preparations were kept for 10 min in ␤-escin-free relaxing solution.
After the ␤-escin skinning procedure, a reference contraction was made in the contracting solution (pCa 4.9). Each strip was placed in relaxing solution for 10 ] without and with GTP␥S and expressed the values relative to force of the reference contraction at pCa 4.9. In separate experiments, the muscles were transferred to a relaxing solution containing 100 M GTP after the initial reference contraction. A contraction was then elicited at intermediate [Ca 2ϩ ] or [Sr 2ϩ ] in the presence of GTP. At the plateau of contraction, 10 Ϫ4 M phenylephrine was added. The increase in force induced by phenylephrine was expressed relative to force of the reference contraction at pCa 4.9.
Solutions for intact preparations. The PSS contained (in mM) 122 NaCl, 4. (11) .
Statistics. Values are means Ϯ SE, with the number of observations in parentheses.
RESULTS

Spontaneous contractile activity and high-K
ϩ -induced force in Ca 2ϩ and Sr 2ϩ solutions in intact muscle. All effects of Sr 2ϩ and Ca 2ϩ in intact muscle were fully reversible and independent of whether Sr 2ϩ experiments were performed before or after the Ca 2ϩ controls. The rat portal vein exhibited spontaneous contractile activity in PSS with 2.5 mM CaCl 2 . In PSS containing 2.5 mM SrCl 2 , the spontaneous contractile activity was also present, although with a slightly more regular pattern (Fig. 1, left) . In SrCl 2 , the frequency of contractions was 1.0 Ϯ 0.1 min Ϫ1 and the force amplitude was 69 Ϯ 6% (n ϭ 6) of the "reference force" (see METHODS) in response to activation with 80 mM K ϩ in 2.5 mM CaCl 2 . The corresponding values for spontaneous activity in CaCl 2 were 2.2 Ϯ 0.3 min Ϫ1 and 54 Ϯ 10% (n ϭ 6).
Activation with 80 mM K ϩ resulted in sustained contractions in CaCl 2 and SrCl 2 (Fig. 1, left and mid Ϫ8 -10 Ϫ7 M norepinephrine increased the amplitude and frequency of the spontaneous activity. After activation at higher norepinephrine concentrations (above ϳ3.0 ϫ 10 Ϫ7 M), a sustained component appeared. If Sr 2ϩ was substituted for Ca 2ϩ , responses at lower norepinephrine concentrations were essentially unaltered. However, no sustained component appeared at high norepinephrine concentrations; instead, the amplitude and frequency of the phasic contractions increased (Fig. 1, right) . In experiments not shown here, we increased the SrCl 2 concentration to 5 and 10 mM and observed no sustained contraction. In Fig. 3 , Fig. 1 . Spontaneous contractile activity, depolarization-induced active force, and norepinephrine (NE) responses in the presence of Ca 2ϩ and Sr 2ϩ . Left: depolarization-induced contractile responses to 80 mM KCl (solid horizontal bar) in 2.5 mM SrCl2 (top trace) and 2.5 mM CaCl2 (bottom trace). After contraction, the muscle was relaxed in Ca 2ϩ /Sr 2ϩ -free physiological saline solution (ticking below trace). Middle and right: the same muscles, but in the presence of CaCl2 (top trace) and SrCl2 (bottom trace). Preparations were activated by 80 mM K ϩ or 10 Ϫ5 M norepinephrine. Note lack of sustained force after norepinephrine activation in the presence of Sr 2ϩ .
summarizing the results at 2.5 mM CaCl 2 and SrCl 2 , the amplitude of the phasic (i.e., baseline to peak force) and sustained (i.e., baseline to sustained force) components are plotted against the norepinephrine concentration. The phasic component reached half-maximal amplitude at ϳ3 ϫ 10 Ϫ8 M norepinephrine in the presence of Ca 2ϩ and at 1 ϫ 10 Ϫ7 M norepinephrine in the presence of Sr 2ϩ . The sustained component reached half-maximal amplitude at ϳ1 ϫ 10 Ϫ6 M norepinephrine in the presence of Ca 2ϩ . It was absent in the presence of Sr 2ϩ . The apparent rate constant of relaxation (determined as the natural logarithm of 2 divided by the time to relax to 50% of peak) was determined during spontaneous contractile activity in PSS. The rate of relaxation of the spontaneous contractions was slightly, although not significantly, faster in the presence of Ca 2ϩ than in the presence of Sr 2ϩ : 0.50 Ϯ 0.05 (n ϭ 12) and 0.36 Ϯ 0.03 s Ϫ1 (n ϭ 6), respectively. In the presence of Sr 2ϩ , the rate of relaxation of the phasic contractions at 10 Ϫ5 M norepinephrine was lowered to 25% of that during spontaneous activity (0.0825 Ϯ 0.007 s Ϫ1 , n ϭ 12, P Ͻ 0.001 compared with spontaneous activity in Ca 2ϩ or Sr 2ϩ ), whereas frequency and amplitude were increased (Figs. 1 and 3) . Ca 2ϩ dependence of the sustained phase during norepinephrine-induced contraction in intact muscle. The experiments described above to study activation with norepinephrine were performed in the continuous presence of Sr 2ϩ or Ca 2ϩ . In an attempt to provoke a sustained contraction phase in the presence of Sr 2ϩ , we added 2.5 mM Ca 2ϩ 3 min after activation with 10 Ϫ5 M norepinephrine in 2.5 mM Sr 2ϩ . This induced irregular contractions but without a sustained phase. This suggests a competition between Sr 2ϩ and Ca 2ϩ in a step involved in the activation of the sustained norepinephrine force. To overcome this interaction but still examine the Ca 2ϩ dependence of the sustained contraction, we performed experiments where the muscle preparation initially was depleted of Ca 2ϩ and Sr 2ϩ using 1 mM EGTA for 10 min. Thereafter, the muscle was exposed to a low concentration of EGTA (0.1 mM) and challenged with 10 Ϫ5 M norepinephrine. This did not cause a contraction. If 2.5 mM Sr 2ϩ was introduced, phasic contractions without any sustained force gradually developed in a manner similar to that described above (Fig. 4, left) . If, instead, 2.5 mM Ca 2ϩ was used, a sustained contraction developed rapidly (Fig. 4,  right) . In the presence of low [Ca 2ϩ ] (0.1 mM EGTA and 0.15 mM CaCl 2 ), norepinephrine did not cause a contraction, showing that this low free [Ca 2ϩ ] (ϳ50 M) did not support contraction by itself (Fig. 4, middle) . If 2.5 mM Sr 2ϩ was added in this situation (Fig. 4,  middle) , a strong contraction developed and was sustained for Ն1 min. Thereafter, the sustained force returned to baseline and a phasic contraction pattern, similar to that observed in the presence of Sr 2ϩ alone, appeared. These results show that a very low free [Ca 2ϩ ], which by itself cannot support contraction, can act as a switch permitting a sustained phase in combination with Sr 2ϩ . In addition, Sr 2ϩ appears to compete with Ca 2ϩ and inhibit this process. Ca 2ϩ and Sr 2ϩ dependence of G protein-mediated sensitization of contraction in ␤-escin-permeabilized preparations. To examine whether the lack of sustained force in the norepinephrine-induced contraction in the presence of Sr 2ϩ was due to a failure of G protein-mediated sensitization of the contractile machinery, we performed experiments on ␤-escin-permeabilized portal veins. Figure 5, Figure 5 , bottom, summarizes the data from permeabilized muscles. The force re- 
DISCUSSION
A rise in intracellular free [Ca 2ϩ ] and sensitization of the contractile machinery to Ca 2ϩ are key features in receptor-mediated agonist activation of smooth muscle (27) . Clear evidence has been presented that the sustained phase of responses to norepinephrine and carbachol is influenced by sensitization (18, 23, 28) . We show here that the sustained phase of norepinephrineinduced contraction in a vascular smooth muscle is dependent also on Ca 2ϩ -specific regulation of a membrane-associated process and that the agonist-induced sensitization of the contractile proteins is not the only mechanism determining the sustained phase.
The sustained phase of norepinephrine-induced contraction was selectively removed when Sr 2ϩ was substituted for Ca 2ϩ . In the presence of Ca 2ϩ , the peak and sustained components of the norepinephrine contraction in the portal vein had different norepinephrine dependencies (cf. Fig. 2 ). On replacement of Ca 2ϩ with Sr 2ϩ , the phasic responses at low norepinephrine concentration were similar. Although the concentrationresponse relationship of the phasic component was shifted slightly toward higher norepinephrine concentrations in the presence of Sr 2ϩ , the response at saturating norepinephrine concentration reached the same amplitude as in the presence of Ca 2ϩ . In contrast, no sustained response appeared, even at very high norepinephrine concentrations (Յ3 ϫ 10 Ϫ5 M). Thus the lack of sustained contraction in the presence of Sr 2ϩ is not due to a shift in the norepinephrine dose-response relationship but, rather, reflects a failure in the adrenergic activation pathway in the presence of Sr 2ϩ . Norepinephrine-induced activation involves Ca 2ϩ release from the sarcoplasmic reticulum (30) . The role of the released Ca 2ϩ is dual: to activate the contractile machinery directly and to regulate Ca 2ϩ -sensitive channel activity, which alters the membrane potential and Ca 2ϩ channel influx (16, 27, 31) . The sarcoplasmic reticulum in phasic muscle, such as the portal vein, is poorly developed (7). Ca 2ϩ release from the sarcoplasmic reticulum primarily contributes to the fast initial phase of contraction (30) . Sr 2ϩ can be sequestered by the sarcoplasmic reticulum (33, 39) in smooth muscle and released (4) . Sr 2ϩ can induce Ca 2ϩ release from the sarcoplasmic reticulum (10). These results suggest that impaired release from the sarcoplasmic reticulum is not responsible for the loss of sustained contraction in the presence of Sr 2ϩ . Previous studies on chemically permeabilized smooth muscle have shown that Sr 2ϩ can activate the contractile proteins and induce myosin light chain phosphorylation (11, 13, 36) , although the concentration dependence is shifted toward higher concentra- . This is consistent with previous results from K ϩ -depolarized swine carotid media (11) showing that Sr 2ϩ can substitute for Ca 2ϩ in the activation of intact smooth muscle. The phosphorylation-stress relationships of depolarized intact smooth muscle have been shown to be similar in the presence of Sr 2ϩ and Ca 2ϩ (11) . These results, together with our finding that the spontaneous activity ( Fig. 1) and high-K ϩ induced force (Fig. 2) were of high amplitude in the presence of Sr 2ϩ , show that the level of phosphorylation can reach the same levels in the presence of Sr 2ϩ and Ca 2ϩ . The presence of a very small [Ca 2ϩ ] can activate the sustained phase in the presence of Sr 2ϩ (Fig. 4) . We find that the effect of Ca 2ϩ in the presence of Sr 2ϩ depended on the order in which the ions were introduced; adding Ca 2ϩ , even at 2.5 mM, after Sr 2ϩ did not result in a sustained phase. In addition, the increase in [Ca 2ϩ ] that resulted in a sustained phase in the presence of Sr 2ϩ (Fig. 4 ) was very low, on the order of 50 M, which, by itself, was too low to induce force, even in fully depolarized muscle (Fig. 2) . We can therefore exclude the possibility that a difference in concentration dependence for activation of the contractile proteins between Sr 2ϩ and Ca 2ϩ is responsible for the lack of sustained force after norepinephrine activation in the presence of Sr 2ϩ . Instead, we propose that Ca 2ϩ has a switchlike action at the membrane level, allowing [Sr 2ϩ ] to be high for a sufficient amount of time to support a sustained phase.
We show, using GTP␥S and GTP/phenylephrine in permeabilized preparations, that the receptor-coupled G protein-mediated sensitization pathway is present in Sr 2ϩ -containing solutions. The increase in force of the phasic component (cf. Figs. 2 and 3 ) and the slowed relaxation after activation with norepinephrine in the presence of Sr 2ϩ are consistent with an inhibition of the phosphatase. Sensitization via G protein-mediated inhibition of the phosphatase is an important mechanism after receptor activation (20, 28) . The sensitization is considered a major mechanism for the induction of the sustained phase (21, 37). Theoretically, it is possible that norepinephrine-induced sustained force could be the result of the inhibition of the myosin light chain phosphatase alone, independently of an increase in free Ca 2ϩ . If a constitutively active Ca 2ϩ -independent light chain kinase is present, inhibition of the phosphatase alone would be sufficient. In a recent study (41) , a Ca 2ϩ -independent light chain kinase, distinct from the myosin light chain kinase, was demonstrated in rat caudal arterial smooth muscle strips and shown to be associated with myofilaments in isolated chicken gizzard. It was suggested that this kinase could have a role in Ca 2ϩ sensitization and Ca 2ϩ -independent contraction of smooth muscle in response to stimuli that act via Ca 2ϩ -independent pathways and inhibition of the phosphatase. If this kinase is operating in the rat portal vein, we can exclude the possibility that it has any physiological significance in preserving the sustained phase in norepinephrine-induced contraction, since we can induce G protein-mediated sensitization without eliciting a sustained component in the presence of Sr 2ϩ . Because the responses of the permeabilized preparations were similar in the presence of Ca 2ϩ and Sr 2ϩ , the lack of a sustained phase in the presence of Sr 2ϩ must be attributed to a membrane-associated mechanism. Two Ca 2ϩ -regulated channels have been suggested to contribute to membrane depolarization after norepinephrine activation in the portal vein (5) (15, 29) ], is active in the right time scale for the sustained phase (29) , and has a substantial conductance (200 pS) in the portal vein (22) suggests that this channel may be important for the sustained phase of the norepinephrine-induced contraction in the intact portal vein. The sustained phase after activation with norepinephrine is mainly dependent on prolonged depolarization activating the L-type Ca 2ϩ channels (26) . This depolarization is postulated to be maintained primarily by the agonistactivated cation channel, possibly in cooperation with the Ca 2ϩ -activated Cl Ϫ channel (32). In conclusion, norepinephrine causes sensitization of the myosin phosphorylation in the presence of Ca 2ϩ and Sr 2ϩ . The sensitization, via small G proteins and inhibition of phosphatase, is activated without the appearance of a sustained contraction in the presence of Sr 2ϩ . Our interpretation of the lack of sustained phase is that the activities of myosin light chain kinase and/or other myosin phosphorylating kinases are insufficient to reach the contractile threshold of light chain phosphorylation, even in the sensitized myofilaments. The results show that sensitization is not sufficient for the sustained phase of agonist-induced contraction. Part of these results has been presented in preliminary form (3).
